302 Results

People

  1. Motzer
    Motzer
  2. Kris
    Kris
  3. Drilon
    Drilon
  4. Zelenetz
    Zelenetz
  5. Gerecitano
    Gerecitano
  6. Horwitz
    Horwitz
  7. Hudis
    Hudis
  8. Miller
    Miller
  9. Moskowitz
    Moskowitz
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (210)
  2. Solid Tumor Oncology Division (127)
  3. Hematologic Malignancies, Division of (81)
  4. Center for Hematologic Malignancies (70)
  5. Genitourinary Oncology Service (39)
  6. Epidemiology and Biostatistics (37)
  7. GSK Faculty (35)
  8. Survivorship Research (34)
  9. Biostatistics Service (32)
  10. Radiology, Department of (31)
  1. "coughing"
Formats
  1. Journal Article (285)
  2. Review (7)
  3. Research Letter (5)
  4. Editorial (2)
  5. Conference Paper (1)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (210)
  2. Solid Tumor Oncology Division (127)
  3. Hematologic Malignancies, Division of (81)
  4. Center for Hematologic Malignancies (70)
  5. Genitourinary Oncology Service (39)
  6. Epidemiology and Biostatistics (37)

More Groups

People
  1. Robert Motzer (22)
  2. Mark Kris (12)
  3. Alexander Drilon (9)
  4. Andrew Zelenetz (9)
  5. Clifford Hudis (8)
  6. John Gerecitano (8)

More People

Years
  1. 2025 (9)
  2. 2024 (24)
  3. 2023 (25)
  4. 2022 (18)
  5. 2021 (14)
  6. 2020 (30)

More Years

Publications
  1. Lancet Oncology (23)
  2. Clinical Cancer Research (22)
  3. Journal of Clinical Oncology (16)
  4. New England Journal of Medicine (15)
  5. Blood (13)
  6. Cancer (13)

More Publications

Publishers
  1. Elsevier Inc. (52)
  2. Elsevier Science, Inc. (37)
  3. American Association for Cancer Research (23)
  4. Nature Publishing Group (21)
  5. Wiley Blackwell (18)
  6. American Society of Clinical Oncology (17)

More Publishers

Results (302)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic chimeric antigen receptor T-cell products cemacabtagene ansegedleucel/ALLO-501 in relapsed/refractory large B-cell lymphoma: Phase I experience from the ALPHA2/ALPHA clinical studies
    Journal Article

    Locke, F. L.; Munoz, J. L.; Tees, M. T.; Lekakis, L. J.; de Vos, S.; Nath, R.; Stevens, D. A.; Malik, S. A.; Shouse, G. P.; Hamadani, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer
    Journal Article

    Gouda, M. A.; Voss, M. H.; Tawbi, H.; Gordon, M.; Tykodi, S. S.; Lam, E. T.; Vaishampayan, U.; Tannir, N. M.; Chaves, J.; Nikolinakos, P.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Systematic review of stereotactic ablative radiotherapy (SABR)/stereotactic body radiation therapy (SBRT) for treatment of high-risk patients with stage I non-small cell lung cancer
    Review

    Wolf, A.; Loo, B. W. Jr; Mak, R. H.; Liptay, M.; Pettiford, B.; Rocco, G.; Lanuti, M.; Merritt, R. E.; Keshavarz, H.; Suh, R. D.; more...
    Seminars in Thoracic and Cardiovascular Surgery (2025)

    Fulltext@MSK | Save
  • Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies
    Research Letter

    Bewersdorf, J. P.; Mi, X.; Lu, B.; Kuykendall, A.; Sallman, D.; Patel, M.; Stevens, D.; Philipovskiy, A.; Sutamtewagul, G.; Masarova, L.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • North American expert consensus on the post-procedural care of patients after per-oral endoscopic myotomy using a Delphi process
    Journal Article

    Yang, D.; Mohammed, A.; Yadlapati, R.; Wang, A. Y.; Jeyalingam, T.; Draganov, P. V.; Gonzaga, E. R.; Hasan, M. K.; Schlachterman, A.; Xu, M. M.; more...
    Clinical Gastroenterology and Hepatology (2025)

    Fulltext@MSK | Save
  • MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
    Journal Article

    Bhutani, M.; Robinson, M.; Foureau, D.; Atrash, S.; Paul, B.; Guo, F.; Grayson, J. M.; Ivanina-Foureau, A.; Pineda-Roman, M.; Varga, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Microwave ablation of refractory oligometastatic non–small cell lung cancer in the liver
    Journal Article

    Geevarghese, R.; Kunin, H.; Petre, E. N.; Deng, R.; Jain, S.; Sotirchos, V. S.; Zhao, K.; Sofocleous, C. T.; Solomon, S. B.; Ziv, E.; more...
    Journal of Vascular and Interventional Radiology (2025)

    Fulltext@MSK | Save
  • Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre study
    Journal Article

    Aguado-Barrera, M. E.; Lopez-Pleguezuelos, C.; Gómez-Caamaño, A.; Calvo-Crespo, P.; Taboada-Valladares, B.; Azria, D.; Boisselier, P.; Briers, E.; Chan, C.; Chang-Claude, J.; more...
    Lung Cancer (2025)

    Fulltext@MSK | Save
  • A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6
    Journal Article

    Hughes, B. G. M.; Guminski, A.; Bowyer, S.; Migden, M. R.; Schmults, C. D.; Khushalani, N. I.; Chang, A. L. S.; Grob, J. J.; Lewis, K. D.; Ansstas, G.; more...
    Journal of the American Academy of Dermatology (2025)

    Fulltext@MSK | Save
  • Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): A multicentre, open-label, single-arm, phase 2 study
    Journal Article

    Zinzani, P. L.; Izutsu, K.; Mehta-Shah, N.; Barta, S. K.; Ishitsuka, K.; Córdoba, R.; Kusumoto, S.; Bachy, E.; Cwynarski, K.; Gritti, G.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save